Bimekizumab in patients with active psoriatic arthritis : results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 178193795
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(19)33161-7
- Title of journal
- Lancet (London, England)
- Article number
- -
- First page
- 427
- Volume
- 395
- Issue
- 10222
- ISSN
- 0140-6736
- Open access status
- Not compliant
- Month of publication
- February
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
11
- Research group(s)
-
B - Musculoskeletal and Dermatological Sciences
- Citation count
- 22
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
